NCT07210801 is a clinical trial of CIEDimplantation in CIED-related Infections, sponsored by Assiut University.

Who is sponsoring NCT07210801?

NCT07210801 is sponsored by Assiut University.

What drugs are being tested in NCT07210801?

Interventions in NCT07210801: CIEDimplantation.

What condition does NCT07210801 study?

NCT07210801 studies CIED-related Infections, CIED Implantation.

Is NCT07210801 still recruiting?

NCT07210801 is currently not yet recruiting. Last updated 7 October 2025.

Last reviewed 2025-10-07 · How we verify

NCT07210801

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CIED Implantation Technique at Assiut University Heart Hospital in Relation to ESC Guidelines

Not yet recruiting Last updated 7 October 2025

What this trial tests

trial testing CIEDimplantation in CIED-related Infections in 200 participants. Not yet recruiting.

Timeline

1 October 2025

Primary endpoint
1 October 2027

1 November 2027

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 October 2025
Primary completion	1 October 2027
Estimated completion	1 November 2027

Drugs / interventions tested

CIEDimplantation

Conditions studied

CIED-related Infections — all drugs for CIED-related Infections →
CIED Implantation — all drugs for CIED Implantation →

Sponsor

Assiut University

Who can join

18 and older, any sex, with CIED-related Infections or CIED Implantation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective observational cohort study will evaluate the extent to which cardiac implantable electronic device (CIED) implantation techniques at Assiut University Heart Hospital (AUHH) align with the evidence-based recommendations of the European Society of Cardiology (ESC).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for CIED-related Infections

Currently open trials in the same condition.

NCT06418048 — INfectious DIsease REgistry BIObank · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07210801 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 7 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07210801.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing